“The revision of the outlook to stable is due largely to CHS’ recent pattern of weaker earnings,” said S&P analyst Margaret McNamara.
The rating affirmation reflects S&P’s view of CHS’ improving balance sheet and leading market position.
More articles on healthcare finance:
Fitch affirms MultiCare Health System’s ‘AA-‘ rating
Moody’s affirms Summit Health’s ‘A2’ rating
Moody’s revises Mercy Hospital’s outlook to negative
